Volume 11, Issue 1 (Feb 2023)                   Res Mol Med (RMM) 2023, 11(1): 37-48 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Malekizadeh G, Jazayeri O, Alijanpour M, Tafrihi M. Gene Frequencies of Methylmalonic Acidemia Disease at the Global Level and Compiling the Pathogenic Mutations in the Iranian Population. , Res Mol Med (RMM). 2023; 11 (1) :37-48
URL: http://rmm.mazums.ac.ir/article-1-489-en.html
1- Department of Molecular and Cell Biology, Faculty of Science, University of Mazandaran, Babolsar, Iran
2- Department of Molecular and Cell Biology, Faculty of Science, University of Mazandaran, Babolsar, Iran , ojazayeri@gmail.com
3- Non-communicable pediatric Disease Research Center, Health Research Institute, Babol University of Medical Science, Babol, Iran
Abstract:   (3672 Views)
Background: Methylmalonic acidemia (MMA) is a rare autosomal recessive metabolic disorder resulting from a genetic defect in methylmalonyl-CoA mutase (MCM) or a defect in the biosynthesis of its cofactor, adenosyl-cobalamin (AdoCbl). The disease is caused by a mutation in six main genes (MUT, MMAA, MMAB, MMADHC, MMACHC, and MCEE). In this investigation, we estimate MMAdisease gene frequencies globally and report MMA-causative mutations in the Iranian population.
Methods: Human gene mutation database (HGMD) has been utilized to estimate MMA-disease gene frequencies. To compile MMA mutations in Iran, we systematically reviewed PubMed, Google Scholar, CIVILICA, Magiran, and SID databases to explore relevant articles in English and Persian.
Results: The frequencies of causative genes among MMA patients at the global level were as follows: MUT (64.14%), MMACHC (17.74%), MMAA (13.48%), MMAB (7.1%), MMADHC (2.9%), and MCEE (0.85%). Until February 11, 2024, 24 MMA mutations had been compiled from the Iranian population; of which 11 mutations (45.8%) had been diagnosed only in Iran and had not been addressed in other populations yet.
Conclusion: Collection and recognition of MMA mutations in the Iranian population can be helpful for early diagnosis and treatment before the onset of neurological manifestations in neonates.
 
Full-Text [PDF 1544 kb]   (1589 Downloads)    
Type of Study: review | Subject: Biology
Published: 2023/03/19

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

Designed & Developed by : Yektaweb